[Mords1938]

commissioner Dr. Amy Abernethy summarized the key points from Friday’s public meeting, including a need to “further clarify the regulatory framework to reduce confusion in the market,” to conduct and gather additional scientific research and data on bionic bliss cbd usage on humans and animals, to create labeling standards, safety thresholds for dosing, and quality standards that include lab testing and data analyses. The FDA regulators have opened a public docket in conjunction with last week’s public meeting. Until July 2, any member of the general public can bionic bliss cbd comment. The FDA is specifically looking for detailed information related to health and safety risks, product quality and manufacturing, and the

http://health2wealth...onic-bliss-cbd/